treatment

Craig S. Sauter, MD

Institution
Cleveland Clinic, Cleveland, OH
Physician Status
accepting new patients
Primary Disease Area of Focus
Acute Myeloid Leukemia (AML)
Chronic Lymphocytic Leukemia (CLL)
Chronic Myelomonocytic Leukaemia (CMML)
Myelodysplastic Syndromes (MDS)

Living with MDS: A Patient Panel

Thumbnail for video Watch Now

Topic(s)
Acute Myeloid Leukemia (AML)
Living Well with Bone Marrow Failure
Myelodysplastic Syndromes (MDS)
Patient panel discussions are a chance to meet some of the inspiring patients, caregivers and parents who are dealing with a bone marrow failure disease. Panel discussions are a bit different from our regular educational webinars so please plan to participate via the Q & A window…

Ask the MDS Expert

Thumbnail for video Watch Now

Topic(s)
Acute Myeloid Leukemia (AML)
Myelodysplastic Syndromes (MDS)
Presenter(s)
Sandrine Niyongere, MD
Dr. Sandrine Niyongere will gives a brief MDS overview and then answer questions from participants. This interactive webinar recorded patients asking questions that are answered directly by a MDS Expert. #MDS #myelodysplasia #bloodcancer

Understanding Integrative, Holistic and Functional Medicine

Thumbnail for video Watch Now

Topic(s)
Acute Myeloid Leukemia (AML)
Aplastic Anemia
Bone Marrow Transplant
Living Well with Bone Marrow Failure
Managing Your Treatment
Myelodysplastic Syndromes (MDS)
Paroxysmal Nocturnal Hemoglobinuria (PNH)
Pediatric Bone Marrow Failure Diseases
Related Bone Marrow Failure Diseases and Malignancies
Presenter(s)
Mikhail Kogan, MD
Dr. Mikhail Kogan, Medical Director of the GW Center for Integrative Medicine, discusses the differences between integrative, holistic and functional medicines and how they can be used to treat patients. The end of the webinar features questions from patients in the audience.

Effective treatment of low risk acute GVHD with itacitinib monotherapy

Original Publication Date
Article Source
External Web Content
Key Points Itacitinib monotherapy is as effective as systemic corticosteroids for the treatment of low risk acute GVHD. Itacitinib monotherapy resulted in fewer serious infections compared to systemic corticosteroids. The standard primary treatment for acute graft vs host disease…

George Chen, MD

Institution
Roswell Park Cancer Center
Physician Status
accepting new patients
Primary Disease Area of Focus
Acute Myeloid Leukemia (AML)
Chronic Lymphocytic Leukemia (CLL)
Chronic Myelomonocytic Leukaemia (CMML)
About
Dr. George Chen is an Associate Professor of Oncology at Roswell Park Cancer Center and associate professor of medicine at Jacobs School of Medicine and Biomedical Sciences. State University of New York at Buffalo. He completed his residency and a fellowship in Houston, TX at Baylor College of medicine and an additional fellowship in Palo Alto, CA at Stanford University. He is board certified in internal medicine, hematology and medical oncology. Dr. Chem has a special interest in stem cell transplant, chronic graft versus host disease and aplastic anemia. He specializes in acute and chronic
Subscribe to treatment

Website Feedback

Please use this feedback form to report website issues only. For other issues concerning patients and families, please email help@aamds.org or use the Patient and Family Helpline here.